Table 2 Perioperative glucose levels of the primary total joint arthroplasty population
Day | Cases (n) | Glucose level (mg/dL) | CV (%)b | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD | Median | Range | Normala (< 100 mg/dL) | Elevateda (100-126 mg/dL) | Stricta (> 126 mg/dL) | Intermediatea (> 137 mg/dL) | Lenienta (> 180 mg/dL) | |||
Total | ||||||||||
PRD | 1463 | 93 ± 26 | 88 | 47-367 | 1133 (77.4%) | 229 (15.7%) | 101 (6.9%) | 69 (4.7%) | 20 (1.4%) | |
POD1 | 1158 | 117 ± 35 | 110 | 40-383 | 388 (33.5%) | 429 (37.0%) | 341 (29.4%) | 228 (19.7%) | 58 (5.0%) | 7.14 |
POD2 | 470 | 104 ± 26 | 97 | 45-227 | 255 (54.3%) | 154 (32.8%) | 61 (13.0%) | 45 (9.6%) | 10 (2.1%) | |
POD3 | 217 | 105 ± 29 | 97 | 67-239 | 119 (54.8%) | 66 (30.4%) | 32 (14.7%) | 22 (10.1%) | 9 (4.1%) | |
POD4 | 205 | 100 ± 24 | 94 | 54-202 | 132 (64.4%) | 46 (22.4%) | 27 (13.2%) | 18 (8.8%) | 4 (2.0%) | |
POD5 | 177 | 96 ± 21 | 94 | 61-238 | 126 (71.2%) | 40 (22.6%) | 11 (6.2%) | 7 (4.0%) | 2 (1.1%) | |
POD6 | 143 | 99 ± 38 | 92 | 52-391 | 99 (69.2%) | 26 (18.2%) | 18 (12.6%) | 13 (9.1%) | 4 (2.8%) | |
Diabetic | ||||||||||
PRD | 194 | 118 ± 45 | 109 | 47-317 | 81 (41.8%) | 53 (27.3%) | 60 (30.9%) | 45 (23.2%) | 14 (7.2%) | |
POD1 | 153 | 144 ± 47 | 139 | 40-364 | 23 (15.0%) | 35 (22.9%) | 95 (62.1%) | 77 (50.3%) | 26 (17.0%) | 9.02 |
POD2 | 59 | 132 ± 40 | 131 | 58-227 | 15 (25.4%) | 14 (23.7%) | 30 (50.8%) | 26 (44.1%) | 7 (11.9%) | |
POD3 | 29 | 127 ± 41 | 115 | 79-230 | 10 (34.5%) | 6 (20.7%) | 13 (44.8%) | 8 (27.6%) | 5 (17.2%) | |
POD4 | 36 | 116 ± 35 | 114 | 54-202 | 13 (36.1%) | 8 (22.2%) | 15 (41.7%) | 9 (25.0%) | 3 (8.3%) | |
POD5 | 19 | 113 ± 26 | 103 | 83-182 | 6 (31.6%) | 9 (47.4%) | 4 (21.1%) | 3 (15.8%) | 1 (5.3%) | |
POD6 | 17 | 125 ± 77 | 101 | 52-391 | 8 (47.1%) | 4 (23.5%) | 5 (29.4%) | 5 (29.4%) | 2 (11.8%) | |
Non-diabetic | ||||||||||
PRD | 1269 | 90 ± 18 | 86 | 52-367 | 1052 (82.9%) | 176 (13.9%) | 41 (3.2%) | 24 (1.9%) | 6 (0.5%) | |
POD1 | 1005 | 113 ± 30 | 108 | 58-383 | 365 (36.3%) | 394 (39.2%) | 246 (24.5%) | 151 (15.0%) | 32 (3.2%) | 6.85 |
POD2 | 411 | 100 ± 21 | 97 | 45-205 | 240 (58.4%) | 140 (34.1%) | 31 (7.5%) | 19 (4.6%) | 3 (0.7%) | |
POD3 | 188 | 101 ± 24 | 95 | 67-239 | 109 (58.0%) | 60 (31.9%) | 19 (10.1%) | 14 (7.4%) | 4 (2.1%) | |
POD4 | 169 | 97 ± 20 | 94 | 65-191 | 119 (70.4%) | 38 (22.5%) | 12 (7.1%) | 9 (5.3%) | 1 (0.6%) | |
POD5 | 158 | 94 ± 20 | 90 | 61-238 | 120 (75.9%) | 31 (19.6%) | 7 (4.4%) | 4 (2.5%) | 1 (0.6%) | |
POD6 | 126 | 96 ± 28 | 90 | 63-306 | 91 (72.2%) | 22 (17.5%) | 13 (10.3%) | 8 (6.3%) | 2 (1.6%) | |